Home Site Map Contact Us
  Back to Salix Products
MoviPrep

Foreign Language
Patient Instructions



Foreign Language Patient Instructions

This information is intended for U.S. residents only.

MoviPrep® is indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MoviPrep offers a tolerable dosing regimen that does not require the use of bisacodyl tablets, thereby avoiding bisacodyl-associated cramping in patients.

To view MoviPrep's simple dosing and easy to follow patient instructions, please click the link below:

Please click below to view MoviPrep's simple dosing and easy to follow patient instruction sheets.

Arabic   Arabic (PDF 1.1MB)
Armenian   Armenian (PDF 1.3MB)
Bosnian   Bosnian (PDF 729KB)
Chinese (Simplified)   Chinese (Simplified) (PDF 692KB)
Chinese (Traditional)   Chinese (Traditional) (PDF 735KB)
Creole (Haitian)   Creole (Haitian) (PDF 698KB)
Farsi   Farsi (PDF 1.5MB)
French   French (PDF 456KB)
Hindi   Hindi (PDF 1.6MB)
  Hmong   Hmong (PDF 407KB)
Japanese   Japanese (PDF 803KB)
Korean   Korean (PDF 642KB)
Polish   Polish (PDF 847KB)
Portuguese   Portuguese (PDF 428KB)
Russian   Russian (PDF 764KB)
Spanish   Spanish (PDF 425KB)
Urdu   Urdu (PDF 2.5MB)
Vietnamese   Vietnamese (PDF 1.24MB)


To view MoviPrep's simple dosing and easy to follow animated video, please click the Play button below:

The Colonoscopy


Get Adobe Acrobat Reader

Get Acrobat Reader

MoviPrep® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MoviPrep is contraindicated in patients who have had a severe hypersensitivity reaction to any of its components. MoviPrep should be used with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities, in patients with known or suspected hyponatremia, severe ulcerative colitis, ileus, gastrointestinal obstruction or perforation, gastric retention, toxic colitis, toxic megacolon, or glucose-6-phosphate dehydrogenase deficiency. In clinical trials, abdominal distention, anal discomfort, thirst, nausea, and abdominal pain were the most common adverse reactions to MoviPrep administration. MoviPrep contains a maximum of 2.33 mg of phenylalanine per treatment.

Consult with your physician to see if this product is right for you.

For complete Prescribing Information, please click here.


For product information, adverse event reports, and product complaint reports please call:

Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email:

  • MoviPrep Physician Resource Center
  • MoviPrep Product Prescribing Information

  • MoviPrep Patient Newsletter

Click here here for Patient Instructions